DANUBE AG |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.3 CHF | +2.53% |
|
+1.15% | +14.46% |
| Apr. 11 | U.S. Futures Down, European Stocks Mixed | DJ |
| Apr. 08 | DSM-Firmenich AG announces an Equity Buyback for 1,500,000 shares, representing 0.6% of its issued share capital. | CI |
| Sales 2024 * | 12.69B 13.57B 12.4B | Sales 2025 * | 13.34B 14.26B 13.03B | Capitalization | 27.93B 29.87B 27.29B |
|---|---|---|---|---|---|
| Net income 2024 * | 478M 511M 467M | Net income 2025 * | 783M 837M 765M | EV / Sales 2024 * | 2.43 x |
| Net Debt 2024 * | 2.93B 3.13B 2.86B | Net Debt 2025 * | 2.65B 2.83B 2.59B | EV / Sales 2025 * | 2.29 x |
| P/E ratio 2024 * |
58.7
x | P/E ratio 2025 * |
35.1
x | Employees | 28,685 |
| Yield 2024 * |
2.33% | Yield 2025 * |
2.36% | Free-Float | 25.03% |
More Fundamentals
* Assessed data
More news
Latest transcript on Danube AG
More press releases
| 1 day | +2.53% | ||
| 1 week | +1.15% | ||
| Current month | -0.09% | ||
| 1 month | -0.34% | ||
| 3 months | +9.57% | ||
| 6 months | +34.36% | ||
| Current year | +14.46% |
1 week
101.15
107.20
1 month
99.20108.65
Current year
85.86108.65
1 year
75.45120.66
3 years
75.45122.06
5 years
75.45122.06
10 years
75.45122.06
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 89-12-31 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 23-08-31 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 23-01-31 | |
Thomas Leysen
CHM | Chairman | 63 | 23-01-31 |
| Director/Board Member | 62 | 23-01-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.82% | 12 M€ | +15.09% | - | |
| 0.51% | 10 M€ | +6.14% | - | |
| 0.37% | 88 M€ | +10.37% | - | |
| 0.22% | 4 M€ | -.--% | - | |
| 0.20% | 6 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 105.3 | +2.53% | 620,967 |
| 24-04-25 | 102.7 | -1.25% | 593,854 |
| 24-04-24 | 104 | -2.03% | 469,436 |
| 24-04-23 | 106.2 | +0.95% | 417,694 |
| 24-04-22 | 105.2 | +1.01% | 585,750 |
End-of-day quote Euronext Amsterdam, April 25, 2024
More quotes
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
Sector
Consumer Goods Conglomerates
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
105.3
EUR
Average target price
119.5
EUR
Spread / Average Target
+13.47%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +14.46% | 29.82B | |
| +11.85% | 869B | |
| 0.00% | 239B | |
| +27.20% | 178B | |
| -7.75% | 126B | |
| -5.21% | 74.17B | |
| -16.00% | 50.82B | |
| -24.57% | 38.6B | |
| +19.71% | 31.74B | |
| +63.27% | 28.73B |
- Stock Market
- Equities
- DSFIR Stock
